Live Breaking News & Updates on Stephan Thalen

Stay updated with breaking news from Stephan thalen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Boehringer Ingelheim: Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease

EMPA-KIDNEY, the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease, provides new evidence for patients commonly seen in clinical practice1,2 Phase III trial also demonstrated ....

Stephan Thalen , Richard Haynes , Lulu Phillips , Anne Whitehouse , Eli Lilly , William Herrington , Sarah Mueller , Carinne Brouillon , Jeff Emmick , Product Development , Oxford Population Health , Boehringer Ingelheim , Lilly Alliance , New England Journal , Associate Professor , Honorary Consultant Nephrologist , Professor Richard Haynes , Human Pharma , Managing Directors , Vice President , Public Engagement ,

Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease

/PRNewswire/ EMPA-KIDNEY phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults. ....

United Kingdom , Rheinland Pfalz , Stephan Thalen , Richard Haynes , Colin Baigent , Lulu Phillips , Anne Whitehouse , Martin Landray , Eli Lilly , William Herrington , Carinne Brouillon , Jeff Emmick , University Of Oxford , Steering Committee , Company Do , Oxford Population Health , Boehringer Ingelheim , Research Council Population Health Unit , Lilly Alliance , Exchange Commission , Product Development , Animal Health , New England Journal , Professor Richard Haynes , Human Pharma , Managing Directors ,

Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care

/PRNewswire/ Despite a similar prevalence of the chronic condition, women diagnosed with heart failure have worse outcomes compared to men. A deeper look. ....

United States , Stephan Thalen , Matt Caffrey , Alanna Morris , Eli Lilly , Jennifer Forsyth , Anita Holz , Global Business Communications , Boehringer Ingelheim Pharmaceuticals Inc , Emory University School Of Medicine , Boehringer Ingelheim , Division Of Cardiology , Boehringer Ingelheim Animal Health In Duluth , Clinical Development , Centers For Disease , Lilly Alliance , Boehringer Ingelheim Corporation , Heart Health , Animal Health , Boehringer Ingelheim Fremont Inc , Hear Your Heart , Heart Failure Reveal Gaps , Associate Professor , Emory University School , Disease Control , Executive Director ,

Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

Rheinland Pfalz , United States , Stephan Thalen , Richard Haynes , Colin Baigent , Waheed Jamal , Sarah Reimer , Anne Whitehouse , Eli Lilly , Martin Landray , William Herrington , Jeff Emmick , University Of Oxford , Steering Committee , Oxford Population Health , Boehringer Ingelheim , Data Monitoring Committee , Population Health Research Unit , Product Development , Clinician Scientist Oxford Population Health , Research Council , Independent Data Monitoring , Medical Research Council , Health Research Unit , Associate Professor William Herrington , Honorary Consultant Nephrologist ,

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessmentEMPA-KIDNE. ....

United Kingdom , Stephan Thalen , Richard Haynes , Colin Baigent , Anne Whitehouse , Martin Landray , Eli Lilly , William Herrington , Mohamed Eid , Jeff Emmick , Boehringer Ingelheim Pharmaceuticals Inc , Clinical Development Medical Affairs , Oxford Population Health , Boehringer Ingelheim , Research Council Population Health Unit , Population Health Research Unit , Boehringer Ingelheim Animal Health In Duluth , Product Development , Research Council , University Of Oxford , Steering Committee , Data Monitoring Committee , Exchange Commission , Boehringer Ingelheim Corporation , Animal Health , Boehringer Ingelheim Fremont Inc ,